(NGVC) Natural Grocers by Vitamin - Overview

Sector: Consumer Defensive | Industry: Grocery Stores | Exchange: NYSE (USA) | Market Cap: 730m USD | Total Return: -36.1% in 12m

Stock Organic Produce, Dietary Supplements, Grocery Staples, Body Care, Pet Care

Total Rating 50

Safety 74

Buy Signal -0.51

Grocery Stores +1.1
Food Retail +0.6

Market Cap: 730m
Avg Trading Vol: 3.20M USD

ATR: 3.55%
Peers RS (IBD): 11.5

Risk 5d forecast

Volatility48.8%

Rel. Tail Risk-12.7%

Reward TTM

Sharpe Ratio-0.64

Alpha-48.49

Character TTM

Beta0.933

Beta Downside1.646

Drawdowns 3y

Max DD59.87%

CAGR/Max DD0.62

EPS (Earnings per Share)

EPS CAGR: 15.94%
EPS Trend: 83.2%

Last SUE: 4.00
Qual. Beats: 2

Revenue

Rev. CAGR: 5.78%
Rev. Trend: 97.9%

Last SUE: -0.01
Qual. Beats: 0

Risks

Technicals: volatile

Description: NGVC Natural Grocers by Vitamin

Natural Grocers by Vitamin Cottage, Inc. (NGVC) is a specialty retailer of natural and organic groceries and dietary supplements in the United States. The company emphasizes organic produce and offers a wide range of private label products across various categories.

The companys offerings extend beyond groceries to include dietary supplements, body care products, pet care items, and household goods. This broad product assortment is common in the natural and organic retail sector, catering to a health-conscious consumer base.

NGVC operates under several brand names, including Natural Grocers and Vitamin Cottage. A key aspect of their business model is providing science-based nutrition education programs, differentiating them in a competitive market.

To gain further insights into NGVCs market position and financial health, consider exploring its detailed financial reports on ValueRay.

Headlines to Watch Out For

Organic food demand drives revenue growth
Private label expansion boosts profit margins
Supply chain disruptions increase operating costs
Regulatory changes impact supplement sales

Piotroski VR‑10 (Strict) 5.5

Net Income: 47.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.14 > 0.02 and ΔFCF/TA 10.34 > 1.0
NWC/Revenue: 0.78% < 20% (prev -0.44%; Δ 1.22% < -1%)
CFO/TA 0.16 > 3% & CFO 108.2m > Net Income 47.8m
Net Debt (301.7m) to EBITDA (95.1m): 3.17 < 3
Current Ratio: 1.07 > 1.5 & < 3
Outstanding Shares: last quarter (23.3m) vs 12m ago 0.35% < -2%
Gross Margin: 29.78% > 18% (prev 0.30%; Δ 2.95k% > 0.5%)
Asset Turnover: 202.8% > 50% (prev 195.7%; Δ 7.12% > 0%)
Interest Coverage Ratio: 22.18 > 6 (EBITDA TTM 95.1m / Interest Expense TTM 2.85m)

Altman Z'' 1.88

A: 0.02 (Total Current Assets 166.8m - Total Current Liabilities 156.4m) / Total Assets 668.6m
B: 0.24 (Retained Earnings 157.2m / Total Assets 668.6m)
C: 0.10 (EBIT TTM 63.3m / Avg Total Assets 658.7m)
D: 0.35 (Book Value of Equity 157.2m / Total Liabilities 448.5m)
Altman-Z'' Score: 1.88 = BBB

Beneish M -3.18

DSRI: 0.80 (Receivables 9.95m/11.9m, Revenue 1.34b/1.27b)
GMI: 0.99 (GM 29.78% / 29.52%)
AQI: 1.13 (AQ_t 0.03 / AQ_t-1 0.02)
SGI: 1.05 (Revenue 1.34b / 1.27b)
TATA: -0.09 (NI 47.8m - CFO 108.2m) / TA 668.6m)
Beneish M-Score: -3.18 (Cap -4..+1) = AA

What is the price of NGVC shares? As of April 05, 2026, the stock is trading at USD 25.85 with a total of 93,610 shares traded.
Over the past week, the price has changed by +0.65%, over one month by -1.80%, over three months by +6.51% and over the past year by -36.06%.

Is NGVC a buy, sell or hold? Natural Grocers by Vitamin has no consensus analysts rating.

What are the forecasts/targets for the NGVC price?

Wallstreet Target Price	54	108.9%
Analysts Target Price	54	108.9%

NGVC Fundamental Data Overview as of 31 March 2026

P/E Trailing = 16.9255
P/E Forward = 31.0559
P/S = 0.4477
P/B = 2.6508
P/EG = 1.44
Revenue TTM = 1.34b USD
EBIT TTM = 63.3m USD
EBITDA TTM = 95.1m USD
Long Term Debt = 324.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 40.7m USD (from shortTermDebt, last quarter)
Debt = 324.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 301.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.03b USD (730.4m + Debt 324.9m - CCE 23.2m)
Interest Coverage Ratio = 22.18 (Ebit TTM 63.3m / Interest Expense TTM 2.85m)
EV/FCF = 11.08x (Enterprise Value 1.03b / FCF TTM 93.1m)
FCF Yield = 9.02% (FCF TTM 93.1m / Enterprise Value 1.03b)
FCF Margin = 6.97% (FCF TTM 93.1m / Revenue TTM 1.34b)
Net Margin = 3.58% (Net Income TTM 47.8m / Revenue TTM 1.34b)
Gross Margin = 29.78% ((Revenue TTM 1.34b - Cost of Revenue TTM 938.3m) / Revenue TTM)
Gross Margin QoQ = 29.46% (prev 29.46%)
Tobins Q-Ratio = 1.54 (Enterprise Value 1.03b / Total Assets 668.6m)
Interest Expense / Debt = 0.22% (Interest Expense 713k / Debt 324.9m)
Taxrate = 18.66% (2.60m / 13.9m)
NOPAT = 51.5m (EBIT 63.3m * (1 - 18.66%))
Current Ratio = 1.07 (Total Current Assets 166.8m / Total Current Liabilities 156.4m)
Debt / Equity = 1.48 (Debt 324.9m / totalStockholderEquity, last quarter 220.0m)
Debt / EBITDA = 3.17 (Net Debt 301.7m / EBITDA 95.1m)
Debt / FCF = 3.24 (Net Debt 301.7m / FCF TTM 93.1m)
Total Stockholder Equity = 207.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.26% (Net Income 47.8m / Total Assets 668.6m)
RoE = 23.11% (Net Income TTM 47.8m / Total Stockholder Equity 207.0m)
RoCE = 11.90% (EBIT 63.3m / Capital Employed (Equity 207.0m + L.T.Debt 324.9m))
RoIC = 24.87% (NOPAT 51.5m / Invested Capital 207.0m)
WACC = 6.47% (E(730.4m)/V(1.06b) * Re(9.27%) + D(324.9m)/V(1.06b) * Rd(0.22%) * (1-Tc(0.19)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.59%
[DCF] Terminal Value 86.77% ; FCFF base≈65.2m ; Y1≈80.4m ; Y5≈137.2m
[DCF] Fair Price = 136.3 (EV 3.43b - Net Debt 301.7m = Equity 3.13b / Shares 23.0m; r=6.47% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 83.16 | EPS CAGR: 15.94% | SUE: 4.0 | # QB: 2
Revenue Correlation: 97.86 | Revenue CAGR: 5.78% | SUE: -0.01 | # QB: 0
EPS next Year (2026-09-30): EPS=2.17 | Chg7d=+2.170 | Chg30d=+2.170 | Revisions Net=+0 | Growth EPS=+11.3% | Growth Revenue=+7.5%

External Resources

Dataroma Stockcircle